XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Redeemable Preferred Stock and Shareholders' Equity - USD ($)
$ in Thousands
Total
Redeemable Preferred Stock
Common Stock
Paid in Capital in Excess of Par
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Balances, beginning of period (in shares) at Dec. 31, 2018   2,500,000 6,176,000      
Balances, beginning of period at Dec. 31, 2018 $ 286,787 $ 49,554 $ 62 $ 0 $ 286,623 $ 102
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 37,853       37,853  
Net unrealized loss from currency translation adjustment, net of tax benefit (expense) (26)         (26)
Net unrealized loss from derivative instruments, net of tax benefit (expense) $ (1,304)         (1,304)
Shares repurchased (in shares) (72,324)   (72,000)      
Shares repurchased $ (3,567)   $ (1) (2,087) (1,479)  
Shares issued under stock compensation plans (in shares)     283,000      
Shares issued under stock compensation plans 163   $ 3 160    
Cancellation of restricted stock in satisfaction of withholding tax (in shares)     (37,000)      
Cancellation of restricted stock in satisfaction of withholding tax (1,460)   $ 0 (1,460)    
Stock-based compensation expense 3,387     3,387    
Accretion of preferred shares issuance costs (42) $ 42     (42)  
Preferred stock dividends (1,611)       (1,611)  
Balances, end of period (in shares) at Jun. 30, 2019   2,500,000 6,350,000      
Balances, end of period at Jun. 30, 2019 320,413 $ 49,596 $ 64 0 321,577 (1,228)
Balances, beginning of period (in shares) at Mar. 31, 2019   2,500,000 6,160,000      
Balances, beginning of period at Mar. 31, 2019 307,438 $ 49,575 $ 62 563 306,912 (99)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 16,975       16,975  
Net unrealized loss from currency translation adjustment, net of tax benefit (expense) (299)         (299)
Net unrealized loss from derivative instruments, net of tax benefit (expense) (830)         (830)
Shares repurchased (in shares)     (65,000)      
Shares repurchased (3,251)   $ (1) (1,771) (1,479)  
Shares issued under stock compensation plans (in shares)     277,000      
Shares issued under stock compensation plans 3   $ 3 0    
Cancellation of restricted stock in satisfaction of withholding tax (in shares)     (22,000)      
Cancellation of restricted stock in satisfaction of withholding tax (914)   $ 0 (914)    
Stock-based compensation expense 2,122     2,122    
Accretion of preferred shares issuance costs (21) $ 21     (21)  
Preferred stock dividends (810)       (810)  
Balances, end of period (in shares) at Jun. 30, 2019   2,500,000 6,350,000      
Balances, end of period at Jun. 30, 2019 320,413 $ 49,596 $ 64 0 321,577 (1,228)
Balances, beginning of period (in shares) at Dec. 31, 2019   2,500,000 6,356,000      
Balances, beginning of period at Dec. 31, 2019 350,338 $ 49,638 $ 64 4,557 348,965 (3,248)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 9,658       9,658  
Net unrealized loss from currency translation adjustment, net of tax benefit (expense) (176)         (176)
Net unrealized loss from derivative instruments, net of tax benefit (expense) $ (2,937)         (2,937)
Shares repurchased (in shares) (54,626)   (55,000)      
Shares repurchased $ (1,490)   $ 0 (1,490) 0  
Shares issued under stock compensation plans (in shares)     311,000      
Shares issued under stock compensation plans 200   $ 3 197    
Cancellation of restricted stock in satisfaction of withholding tax (in shares)     (60,000)      
Cancellation of restricted stock in satisfaction of withholding tax (1,194)   $ (1) (1,193)    
Stock-based compensation expense 5,132     5,132    
Accretion of preferred shares issuance costs (42) $ 42     (42)  
Preferred stock dividends (1,621)       (1,621)  
Balances, end of period (in shares) at Jun. 30, 2020   2,500,000 6,552,000      
Balances, end of period at Jun. 30, 2020 357,868 $ 49,680 $ 66 7,203 356,960 (6,361)
Balances, beginning of period (in shares) at Mar. 31, 2020   2,500,000 6,344,000      
Balances, beginning of period at Mar. 31, 2020 353,007 $ 49,659 $ 63 6,527 352,420 (6,003)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 5,372       5,372  
Net unrealized loss from currency translation adjustment, net of tax benefit (expense) (5)         (5)
Net unrealized loss from derivative instruments, net of tax benefit (expense) (353)         (353)
Shares repurchased (in shares)     (55,000)      
Shares repurchased (1,490)     (1,490)    
Shares issued under stock compensation plans (in shares)     307,000      
Shares issued under stock compensation plans 0   $ 3 (3)    
Cancellation of restricted stock in satisfaction of withholding tax (in shares)     (44,000)      
Cancellation of restricted stock in satisfaction of withholding tax (846)   $ 0 (846)    
Stock-based compensation expense 3,015     3,015    
Accretion of preferred shares issuance costs (21) $ 21     (21)  
Preferred stock dividends (811)       (811)  
Balances, end of period (in shares) at Jun. 30, 2020   2,500,000 6,552,000      
Balances, end of period at Jun. 30, 2020 $ 357,868 $ 49,680 $ 66 $ 7,203 $ 356,960 $ (6,361)